Phase II trial of the ultra-rapid-acting insulins, BIOD 105 and BIOD 107, compared with insulin lispro, in patients with diabetes mellitus.
Phase of Trial: Phase II
Latest Information Update: 27 Sep 2011
At a glance
- Drugs Insulin; Insulin lispro
- Indications Diabetes mellitus
- Focus Therapeutic Use
- 27 Sep 2011 Status changed from planning to discontinued.
- 15 Mar 2011 New trial record